Theratechnologies (TSE:TH) Stock Passes Above Fifty Day Moving Average – Time to Sell?

Theratechnologies Inc. (TSE:TH)’s stock price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$1.73 and traded as high as C$1.85. Theratechnologies shares last traded at C$1.83, with a volume of 35,642 shares traded.

Theratechnologies Stock Up 4.0 %

The company has a debt-to-equity ratio of 562.07, a quick ratio of 0.64 and a current ratio of 1.10. The stock’s fifty day simple moving average is C$1.73 and its two-hundred day simple moving average is C$1.82. The stock has a market capitalization of C$84.14 million, a P/E ratio of -10.17, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73.

Theratechnologies (TSE:TH) last issued its quarterly earnings results on Thursday, October 10th. The company reported C$0.09 EPS for the quarter. The company had revenue of C$30.96 million for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. As a group, research analysts expect that Theratechnologies Inc. will post 0.0298643 EPS for the current fiscal year.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.